Hideharu Odai
- Molecular Biology
- Cell Biology top 10%
- Oncology
- Pharmacology top 5%
- Cardiology and Cardiovascular Medicine
- Co-authors
- Ko SasakiYutaka HanazonoKinuko MitaniHisamaru HiraiYoshio YazakiAkihiro IwamatsuKozo KaibuchiShinichi Oikawa
- Topics
- Protein Kinase Regulation and GTPase Signaling (7 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)Glycosylation and Glycoproteins Research (2 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hideharu Odai
21 papers receiving 840 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 529
- Cell Biology 138
- Oncology 134
- Pharmacology 134
- Cardiology and Cardiovascular Medicine 87
Countries citing papers authored by Hideharu Odai
This map shows the geographic impact of Hideharu Odai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Odai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Odai more than expected).
Fields of papers citing papers by Hideharu Odai
This network shows the impact of papers produced by Hideharu Odai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Odai. The network helps show where Hideharu Odai may publish in the future.
Co-authorship network of co-authors of Hideharu Odai
This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Odai. A scholar is included among the top collaborators of Hideharu Odai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Odai. Hideharu Odai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 74 | |
| 2 | 138 | |
| 3 | 61 | |
| 4 | 106 | |
| 5 | 71 | |
| 6 | 41 | |
| 7 | The signal transduction through Grb2/Ash in hematopoietic cells. | 7 |
| 8 | 12 | |
| 9 | 2 | |
| 10 | 165 | |
| 11 | 17 | |
| 12 | 6 | |
| 13 | 53 | |
| 14 | 11 | |
| 15 | 2 | |
| 16 | 15 | |
| 17 | 15 | |
| 18 | 20 | |
| 19 | 3 | |
| 20 | 1 |
About Hideharu Odai
Hideharu Odai is a scholar working on Toxicology, Molecular Biology and Pharmacology, having authored 21 papers that have together received 858 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (7 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Pharmacology (134 citations), Cell Biology (138 citations) and Molecular Biology (529 citations). Hideharu Odai has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Ko Sasaki, Yutaka Hanazono, Kinuko Mitani, Hisamaru Hirai, Yoshio Yazaki, Akihiro Iwamatsu, Kozo Kaibuchi, Shinichi Oikawa, Keiji Kondô and Tomoyuki Tanaka. Their work appears in journals such as Journal of Biological Chemistry, Blood and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.